Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Revenue grows 17% year over year to $4.6 MillionGAAP Loss of $25,000, or $0.00 per ShareNon-GAAP Income of $284,000, or $0.02 per ShareAdjusted EBITDA of $685,000 TEMPLE CITY, Calif., Aug. 07, 2017 ...
-
TEMPLE CITY, Calif., July 31, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its second quarter 2017...
-
Revenue grows 54% year over year to $5.3 MillionGAAP Income of $0.2 Million, or $0.01 per ShareNon-GAAP Income of $0.6 Million, or $0.03 per ShareAdjusted EBITDA of $1.2 MillionCash Flow from...
-
TEMPLE CITY, Calif., April 25, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that its first quarter 2017 financial results will...
-
Fourth Quarter Revenue doubles year over year to $5.9 Million and reaches $18.3 Million for the Full Year of 2016Fourth Quarter 2016 GAAP Income totals $0.8 Million, or $0.05 per ShareFourth Quarter...
-
TEMPLE CITY, Calif., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) today announced that Ming Hsieh, Chairman and Chief Executive Officer, and Paul Kim, Chief Financial...
-
TEMPLE CITY, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (Nasdaq:FLGT) (“Fulgent Genetics” or the “company”) today announced that its fourth quarter and full year 2016...
-
TEMPLE CITY, Calif., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (Nasdaq:FLGT) today announced that Ming Hsieh, Chairman and Chief Executive Officer, and Paul Kim, Chief Financial...
-
Revenue Grows 72% to $5.0 Million Over Third Quarter of Last YearGAAP Net Loss of $1.0 Million; non-GAAP Earnings of $1.1 MillionGross Margin, Adjusted EBITDA and Cash Flow Continue to Grow TEMPLE...
-
TEMPLE CITY, Calif., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (Nasdaq:FLGT) (“Fulgent Genetics” or the “company”) today announced that its third quarter 2016 financial results...